$CALX
CALIX, INC

2021 Q2 Form 10-Q Financial Statement

#000140666621000039 Filed on April 27, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q1
Revenue $162.1M $101.7M
YoY Change 36.17% 13.8%
Cost Of Revenue $75.83M $56.06M
YoY Change 21.1% 9.9%
Gross Profit $86.24M $45.62M
YoY Change 52.9% 18.99%
Gross Profit Margin 53.21% 44.87%
Selling, General & Admin $41.08M $31.29M
YoY Change 26.25% 11.26%
% of Gross Profit 47.63% 68.59%
Research & Development $24.36M $20.67M
YoY Change 16.46% 6.94%
% of Gross Profit 28.25% 45.31%
Depreciation & Amortization $4.077M $3.544M
YoY Change 17.49% 55.37%
% of Gross Profit 4.73% 7.77%
Operating Expenses $65.44M $51.96M
YoY Change 9.54% 9.5%
Operating Profit $20.80M -$6.340M
YoY Change -723.19% -30.43%
Interest Expense -$125.0K -$290.0K
YoY Change -79.74% 168.52%
% of Operating Profit -0.6%
Other Income/Expense, Net $88.00K $15.00K
YoY Change -180.73% -103.84%
Pretax Income $20.77M -$6.615M
YoY Change -610.95% -31.18%
Income Tax $150.0K $329.0K
% Of Pretax Income 0.72%
Net Earnings $20.62M -$6.944M
YoY Change -589.43% -28.9%
Net Earnings / Revenue 12.72% -6.83%
Basic Earnings Per Share $0.33 -$0.12
Diluted Earnings Per Share $0.31 -$0.12
COMMON SHARES
Basic Shares Outstanding 62.55M shares 56.54M shares
Diluted Shares Outstanding 67.02M shares 56.54M shares

Balance Sheet

Concept 2021 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $150.0M $46.20M
YoY Change 196.44% 4.76%
Cash & Equivalents $85.85M $46.19M
Short-Term Investments $64.20M
Other Short-Term Assets $13.10M $11.80M
YoY Change 7.38% 11.32%
Inventory $72.21M $30.54M
Prepaid Expenses
Receivables $74.41M $67.14M
Other Receivables $0.00 $0.00
Total Short-Term Assets $309.8M $155.7M
YoY Change 95.97% -0.87%
LONG-TERM ASSETS
Property, Plant & Equipment $20.10M $20.40M
YoY Change -4.12% -22.64%
Goodwill $116.2M $116.2M
YoY Change 0.0% 0.0%
Intangibles $8.859M $11.49M
YoY Change -18.22%
Long-Term Investments
YoY Change
Other Assets $11.07M $16.55M
YoY Change -26.3% 1034.34%
Total Long-Term Assets $158.4M $168.3M
YoY Change -2.99% 4.51%
TOTAL ASSETS
Total Short-Term Assets $309.8M $155.7M
Total Long-Term Assets $158.4M $168.3M
Total Assets $468.1M $324.1M
YoY Change 45.69% 1.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $29.22M $20.46M
YoY Change 186.4% -40.38%
Accrued Expenses $56.03M $57.98M
YoY Change -13.38% 4.76%
Deferred Revenue $24.13M $19.91M
YoY Change 47.48% 27.94%
Short-Term Debt $0.00 $30.00M
YoY Change -100.0% -5.36%
Long-Term Debt Due $4.600M
YoY Change
Total Short-Term Liabilities $109.4M $128.4M
YoY Change -6.71% -5.09%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $11.54M $13.49M
YoY Change -15.95% 330.44%
Total Long-Term Liabilities $11.54M $13.49M
YoY Change -15.95% 330.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $109.4M $128.4M
Total Long-Term Liabilities $11.54M $13.49M
Total Liabilities $153.4M $173.1M
YoY Change -5.38% 0.48%
SHAREHOLDERS EQUITY
Retained Earnings -$648.5M -$709.5M
YoY Change -9.14% 2.14%
Common Stock $963.4M $901.5M
YoY Change 5.41% 2.33%
Preferred Stock
YoY Change
Treasury Stock (at cost) $39.99M
YoY Change 0.0%
Treasury Stock Shares 5.330M shares
Shareholders Equity $314.7M $150.9M
YoY Change
Total Liabilities & Shareholders Equity $468.1M $324.1M
YoY Change 45.69% 1.86%

Cashflow Statement

Concept 2021 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income $20.62M -$6.944M
YoY Change -589.43% -28.9%
Depreciation, Depletion And Amortization $4.077M $3.544M
YoY Change 17.49% 55.37%
Cash From Operating Activities $9.898M $1.249M
YoY Change 267.96% -434.85%
INVESTING ACTIVITIES
Capital Expenditures $2.274M $1.729M
YoY Change -182.69% -65.69%
Acquisitions
YoY Change
Other Investing Activities -$11.19M
YoY Change
Cash From Investing Activities -$13.47M -$1.729M
YoY Change 389.67% -65.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $8.639M $80.00K
YoY Change 95.01% -120.51%
NET CHANGE
Cash From Operating Activities $9.898M $1.249M
Cash From Investing Activities -$13.47M -$1.729M
Cash From Financing Activities $8.639M $80.00K
Net Change In Cash $5.047M -$640.0K
YoY Change 15.49% -88.53%
FREE CASH FLOW
Cash From Operating Activities $9.898M $1.249M
Capital Expenditures $2.274M $1.729M
Free Cash Flow $7.624M -$480.0K
YoY Change 40.15% -91.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001406666
CY2021Q2 dei Amendment Flag
AmendmentFlag
false
CY2021Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:AccruedLiabilitiesCurrent
CY2021Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
2777 Orchard Parkway
CY2021Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
San Jose
CY2021Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95134
CY2021Q2 dei City Area Code
CityAreaCode
408
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2021Q2 dei Document Type
DocumentType
10-Q
CY2021Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q2 dei Document Period End Date
DocumentPeriodEndDate
2021-04-03
CY2021Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q2 dei Entity File Number
EntityFileNumber
001-34674
CY2021Q2 dei Entity Registrant Name
EntityRegistrantName
Calix, Inc
CY2021Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
68-0438710
CY2021Q2 dei Local Phone Number
LocalPhoneNumber
514-3000
CY2021Q2 dei Security12b Title
Security12bTitle
Common Stock, par value $0.025 per share
CY2021Q2 dei Trading Symbol
TradingSymbol
CALX
CY2021Q2 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
69419000 USD
CY2021Q2 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2021Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q2 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
62853519 shares
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
85854000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
80807000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
64174000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
52982000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
74408000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
72211000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
52268000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13122000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11414000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
309769000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
266890000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20103000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20381000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11015000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11741000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
116175000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
116175000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11073000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12165000 USD
CY2021Q2 us-gaap Assets
Assets
468135000 USD
CY2020Q4 us-gaap Assets
Assets
427352000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
29224000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
13115000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
56031000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
68736000 USD
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
24127000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
19189000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
109382000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
101040000 USD
CY2021Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
20329000 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
19904000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12167000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12946000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11542000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13137000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
153420000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
147027000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.025
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.025
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.025
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.025
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62851000 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62851000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62122000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62122000 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
1572000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
1553000 USD
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
961846000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
948055000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-226000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-191000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-648477000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-669092000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
314715000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
280325000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
468135000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
427352000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
162074000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
101682000 USD
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
75832000 USD
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
56058000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
86242000 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
45624000 USD
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
28051000 USD
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20624000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24364000 USD
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20671000 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13025000 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10669000 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
65440000 USD
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
51964000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
20802000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-6340000 USD
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-125000 USD
CY2020Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-290000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
88000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15000 USD
CY2021Q2 calx Interest And Other Income Expense Nonoperating
InterestAndOtherIncomeExpenseNonoperating
-37000 USD
CY2020Q1 calx Interest And Other Income Expense Nonoperating
InterestAndOtherIncomeExpenseNonoperating
-275000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
20765000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6615000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
150000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
329000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
20615000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-6944000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62554000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56540000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67019000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56540000 shares
CY2021Q2 us-gaap Profit Loss
ProfitLoss
20615000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-6944000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-35000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-252000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
20580000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-7196000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
280325000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5171000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
8639000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
20615000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-35000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
314715000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
154028000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2984000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1099000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-6944000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-252000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
150915000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
20615000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-6944000 USD
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
5171000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2984000 USD
CY2021Q2 us-gaap Depreciation
Depreciation
4077000 USD
CY2020Q1 us-gaap Depreciation
Depreciation
3544000 USD
CY2021Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4989000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
20627000 USD
CY2021Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
19943000 USD
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-9614000 USD
CY2021Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1321000 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-758000 USD
CY2021Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
16156000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
9472000 USD
CY2021Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-12856000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1367000 USD
CY2021Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5362000 USD
CY2020Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2071000 USD
CY2021Q2 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-2374000 USD
CY2020Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-990000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9898000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1249000 USD
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2274000 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1729000 USD
CY2021Q2 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
54192000 USD
CY2020Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0 USD
CY2021Q2 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
43000000 USD
CY2020Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
0 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13466000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1729000 USD
CY2021Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8639000 USD
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1099000 USD
CY2021Q2 calx Payments For Financing Arrangements
PaymentsForFinancingArrangements
0 USD
CY2020Q1 calx Payments For Financing Arrangements
PaymentsForFinancingArrangements
842000 USD
CY2021Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
CY2020Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
30000000 USD
CY2021Q2 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
CY2020Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
30000000 USD
CY2021Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2020Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
177000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8639000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
80000 USD
CY2021Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-24000 USD
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-240000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5047000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-640000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
80807000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47457000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
85854000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46817000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
85854000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
80807000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
64174000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
52982000 USD
CY2021Q2 calx Cash Cash Equivalents And Marketable Securities
CashCashEquivalentsAndMarketableSecurities
150028000 USD
CY2020Q4 calx Cash Cash Equivalents And Marketable Securities
CashCashEquivalentsAndMarketableSecurities
133789000 USD
CY2021Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
75594000 USD
CY2020Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
70824000 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1186000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1405000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
74408000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
69419000 USD
CY2021Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
58000 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
34000 USD
CY2021Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
72153000 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
52234000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
72211000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
52268000 USD
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
65639000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
66239000 USD
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
45536000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
45858000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20103000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20381000 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8859000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9517000 USD
CY2021Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
2214000 USD
CY2020Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
2648000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11073000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12165000 USD
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
15031000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
23740000 USD
CY2021Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
9650000 USD
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
9208000 USD
CY2021Q2 calx Taxes Payable Current Excluding Accrued Income Taxes
TaxesPayableCurrentExcludingAccruedIncomeTaxes
4220000 USD
CY2020Q4 calx Taxes Payable Current Excluding Accrued Income Taxes
TaxesPayableCurrentExcludingAccruedIncomeTaxes
3476000 USD
CY2021Q2 calx Accrued Excess And Obsolete Inventory At Contract Manufacturer
AccruedExcessAndObsoleteInventoryAtContractManufacturer
4213000 USD
CY2020Q4 calx Product Return Reserve Current
ProductReturnReserveCurrent
1888000 USD
CY2020Q4 calx Accrued Excess And Obsolete Inventory At Contract Manufacturer
AccruedExcessAndObsoleteInventoryAtContractManufacturer
3992000 USD
CY2021Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3713000 USD
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4497000 USD
CY2021Q2 calx Accrued Customer Rebates
AccruedCustomerRebates
3704000 USD
CY2020Q4 calx Accrued Customer Rebates
AccruedCustomerRebates
8374000 USD
CY2021Q2 calx Revenue Share Obligation Current
RevenueShareObligationCurrent
3409000 USD
CY2020Q4 calx Revenue Share Obligation Current
RevenueShareObligationCurrent
2925000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3019000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2994000 USD
CY2021Q2 calx Product Return Reserve Current
ProductReturnReserveCurrent
2244000 USD
CY2021Q2 calx Accrued Freight
AccruedFreight
1892000 USD
CY2020Q4 calx Accrued Freight
AccruedFreight
1955000 USD
CY2021Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
323000 USD
CY2020Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
408000 USD
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4613000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5279000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
56031000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
68736000 USD
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
9208000 USD
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
7294000 USD
CY2021Q2 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
1202000 USD
CY2020Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
1349000 USD
CY2021Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
760000 USD
CY2020Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1213000 USD
CY2021Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
9650000 USD
CY2020Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
7430000 USD
CY2020Q4 us-gaap Restructuring Reserve
RestructuringReserve
1376000 USD
CY2021Q2 us-gaap Payments For Restructuring
PaymentsForRestructuring
146000 USD
CY2021Q2 us-gaap Restructuring Reserve
RestructuringReserve
1230000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2903000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3809000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3915000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3725000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3218000 USD
CY2021Q2 calx Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
42000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
17612000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2426000 USD
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
15186000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3019000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12167000 USD
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
15186000 USD
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.067
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y
CY2020Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
1100000 USD
CY2021Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
1100000 USD
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
1000000.0 USD
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1000000.0 USD
CY2021Q2 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
107800000 USD
CY2021Q2 calx Accrued Excess And Obsolete Inventory At Contract Manufacturer
AccruedExcessAndObsoleteInventoryAtContractManufacturer
4200000 USD
CY2020Q4 calx Accrued Excess And Obsolete Inventory At Contract Manufacturer
AccruedExcessAndObsoleteInventoryAtContractManufacturer
4000000.0 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
100000 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
33.20
CY2021Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
500000 shares
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.36
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
26100000 USD
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y6M
CY2021Q2 calx Number Of Employee Stock Purchase Plans
NumberOfEmployeeStockPurchasePlans
2 Plan
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5171000 USD
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2984000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
162074000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
101682000 USD
CY2020Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
2300000 USD
CY2021Q2 calx Contractwith Customer Asset Prior Period Not Recognized
ContractwithCustomerAssetPriorPeriodNotRecognized
1000000.0 USD
CY2021Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1900000 USD
CY2021Q2 calx Contract With Customer Asset Expected To Be Billed Remainder Of Year Percent
ContractWithCustomerAssetExpectedToBeBilledRemainderOfYearPercent
0.73
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
24127000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
19189000 USD
CY2021Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
20329000 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
19904000 USD
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
44456000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
39093000 USD
CY2021Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
8300000 USD
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
75100000 USD
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.39
CY2021Q2 us-gaap Capitalized Contract Cost Gross
CapitalizedContractCostGross
1400000 USD
CY2021Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
100000 USD
CY2021Q2 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 USD
CY2021Q2 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
150000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
329000 USD
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.007
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.050
CY2021Q2 us-gaap Profit Loss
ProfitLoss
20615000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-6944000 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62554000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56540000 shares
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4465000 shares
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67019000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56540000 shares
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
415000 shares
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7133000 shares

Files In Submission

Name View Source Status
0001406666-21-000039-index-headers.html Edgar Link pending
0001406666-21-000039-index.html Edgar Link pending
0001406666-21-000039.txt Edgar Link pending
0001406666-21-000039-xbrl.zip Edgar Link pending
calx-20210403.htm Edgar Link pending
calx-20210403.xsd Edgar Link pending
calx-20210403_cal.xml Edgar Link unprocessable
calx-20210403_def.xml Edgar Link unprocessable
calx-20210403_htm.xml Edgar Link completed
calx-20210403_lab.xml Edgar Link unprocessable
calx-20210403_pre.xml Edgar Link unprocessable
calx_21q1ex311.htm Edgar Link pending
calx_21q1ex312.htm Edgar Link pending
calx_21q1ex321.htm Edgar Link pending
exhibit101calixamendedandr.htm Edgar Link pending
exhibit102non-employeedire.htm Edgar Link pending
exhibit103non-employeedire.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending